Jak/STAT 通路。
The Jak/STAT pathway.
机构信息
Department of Biology, University of Kentucky, Lexington, Kentucky 40506, USA.
出版信息
Cold Spring Harb Perspect Biol. 2012 Mar 1;4(3):a011205. doi: 10.1101/cshperspect.a011205.
Abstract
The Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathway mediates cellular responses to cytokines (e.g., IL-6) and growth factors (e.g., EGF).
摘要
Janus 激酶/信号转导子和转录激活子（JAK/STAT）信号通路介导细胞对细胞因子（如白细胞介素 6 [IL-6]）和生长因子（如表皮生长因子 [EGF]）的反应。
相似文献
1
The Jak/STAT pathway.Jak/STAT 通路。
Cold Spring Harb Perspect Biol. 2012 Mar 1;4(3):a011205. doi: 10.1101/cshperspect.a011205.
2
SnapShot: Jak-STAT Signaling II.快照：Jak-STAT 信号转导 II。
Cell. 2020 Jun 25;181(7):1696-1696.e1. doi: 10.1016/j.cell.2020.04.052.
3
[JAK/STAT: from inflammation to memory].[JAK/STAT：从炎症到记忆]
Med Sci (Paris). 2012 May;28(5):456-8. doi: 10.1051/medsci/2012285004. Epub 2012 May 30.
4
The Specific Roles of JAK/STAT Signaling Pathway in Sepsis.JAK/STAT信号通路在脓毒症中的特定作用
Inflammation. 2015 Aug;38(4):1599-608. doi: 10.1007/s10753-015-0135-z.
5
An insight into JAK-STAT signalling in dermatology.皮肤病学中JAK-STAT信号通路的深入剖析。
Clin Exp Dermatol. 2014 Jun;39(4):513-8. doi: 10.1111/ced.12273.
6
JAK-STAT signaling: from interferons to cytokines.JAK-STAT信号传导：从干扰素到细胞因子
J Biol Chem. 2007 Jul 13;282(28):20059-63. doi: 10.1074/jbc.R700016200. Epub 2007 May 14.
7
JAK/STAT pathway in Drosophila immunity.果蝇免疫中的 JAK/STAT 通路。
Scand J Immunol. 2014 Jun;79(6):377-85. doi: 10.1111/sji.12170.
8
JAK/STAT pathway modulation: Does it work in dermatology?JAK/STAT 通路调节：在皮肤科有效吗？
Dermatol Ther. 2019 May;32(3):e12903. doi: 10.1111/dth.12903. Epub 2019 Apr 25.
9
JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?致癌作用中的JAK-STAT信号通路：它与胆管癌进展相关吗？
World J Gastroenterol. 2007 Dec 28;13(48):6478-91. doi: 10.3748/wjg.v13.i48.6478.
10
JAK/STAT Signal Transduction: Promising Attractive Targets for Immune, Inflammatory and Hematopoietic Diseases.JAK/STAT 信号转导：免疫、炎症和血液疾病有吸引力的潜在靶点。
Curr Drug Targets. 2018;19(5):487-500. doi: 10.2174/1389450117666161207163054.
引用本文的文献
1
Janus kinase inhibitors - a role for the treatment of cutaneous T-cell lymphomas?Janus激酶抑制剂——在皮肤T细胞淋巴瘤治疗中的作用？
Oncol Rev. 2025 Aug 11;19:1482866. doi: 10.3389/or.2025.1482866. eCollection 2025.
2
Peptidomic and Proteomic Signatures in Human Blood Serum, Follicular Fluid and Spent Media: A Study of Embryo Development Competency after In Vitro Fertilization.人血清、卵泡液和废弃培养基中的肽组学和蛋白质组学特征：体外受精后胚胎发育能力的研究
Reprod Sci. 2025 Jul 15. doi: 10.1007/s43032-025-01933-4.
3
Lymphocytes and monocytes undergo swift suppression of IL-10R, IL-6R, and IL-2Rβγ signaling under high concentrations of different cytokines.在高浓度不同细胞因子作用下，淋巴细胞和单核细胞的白细胞介素-10受体（IL-10R）、白细胞介素-6受体（IL-6R）和白细胞介素-2受体βγ（IL-2Rβγ）信号传导会迅速受到抑制。
bioRxiv. 2025 May 8:2025.05.02.651967. doi: 10.1101/2025.05.02.651967.
4
5
T-cell acute lymphoblastic leukaemia: subtype prevalence, clinical outcome, and emerging targeted treatments.T细胞急性淋巴细胞白血病：亚型患病率、临床结局及新兴靶向治疗
Leukemia. 2025 Apr 17. doi: 10.1038/s41375-025-02599-2.
6
Combining Experimental Validation and Network Pharmacology to Reveal the Action Mechanism of Panax Notoginseng-Radix Salviae on Atherosclerosis.结合实验验证与网络药理学揭示三七-丹参对动脉粥样硬化的作用机制
J Inflamm Res. 2025 Apr 9;18:4929-4945. doi: 10.2147/JIR.S508025. eCollection 2025.
7
Ligand Discrimination in Immune Cells: Signal Processing Insights into Immune Dysfunction in ER+ Breast Cancer.免疫细胞中的配体识别：对雌激素受体阳性乳腺癌免疫功能障碍的信号处理见解
bioRxiv. 2025 Feb 17:2025.02.15.638458. doi: 10.1101/2025.02.15.638458.
8
Evaluation of the In Vivo Efficacy of the JAK Inhibitor AZD1480 in Uterine Leiomyomas Using a Patient-derived Xenograft Murine Model.使用患者来源的异种移植小鼠模型评估JAK抑制剂AZD1480在子宫平滑肌瘤中的体内疗效。
Reprod Sci. 2025 Feb;32(2):417-427. doi: 10.1007/s43032-024-01775-6. Epub 2024 Dec 29.
9
: regulatory roles, cancer-associated signaling pathway disruptions, and therapeutic potential.调节作用、癌症相关信号通路破坏及治疗潜力。
Expert Opin Ther Targets. 2024 Dec;28(12):1061-1091. doi: 10.1080/14728222.2024.2433687. Epub 2024 Dec 8.
10
Optimizing Niclosamide for Cancer Therapy: Improving Bioavailability via Structural Modification and Nanotechnology.优化氯硝柳胺用于癌症治疗：通过结构修饰和纳米技术提高生物利用度
Cancers (Basel). 2024 Oct 21;16(20):3548. doi: 10.3390/cancers16203548.
本文引用的文献
1
Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies.细胞因子信号传导和骨髓增殖性疾病中的Jak/STAT信号通路：靶向治疗方法
Genes Cancer. 2010 Oct;1(10):979-93. doi: 10.1177/1947601910397187.
2
Perspectives for the use of structural information and chemical genetics to develop inhibitors of Janus kinases.利用结构信息和化学遗传学开发 Janus 激酶抑制剂的前景。
J Cell Mol Med. 2010 Mar;14(3):504-27. doi: 10.1111/j.1582-4934.2010.01018.x. Epub 2010 Jan 28.
3
JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin.JAK2使组蛋白H3Y41磷酸化，并将HP1α排除在染色质之外。
Nature. 2009 Oct 8;461(7265):819-22. doi: 10.1038/nature08448. Epub 2009 Sep 27.
4
Janus kinases in immune cell signaling.免疫细胞信号传导中的 Janus 激酶
Immunol Rev. 2009 Mar;228(1):273-87. doi: 10.1111/j.1600-065X.2008.00754.x.
5
Canonical and non-canonical JAK-STAT signaling.经典和非经典JAK-STAT信号传导。
Trends Cell Biol. 2008 Nov;18(11):545-51. doi: 10.1016/j.tcb.2008.08.008. Epub 2008 Oct 9.
6
Inteferons pen the JAK-STAT pathway.干扰素开启JAK-STAT信号通路。 （注：原文中“ Inteferons ”应改为“ Interferons” ）
Semin Cell Dev Biol. 2008 Aug;19(4):311-8. doi: 10.1016/j.semcdb.2008.08.010. Epub 2008 Aug 26.
7
Therapeutic targeting of Janus kinases.Janus激酶的治疗靶点
Immunol Rev. 2008 Jun;223:132-42. doi: 10.1111/j.1600-065X.2008.00644.x.
8
JAK/STAT signalling in Drosophila: insights into conserved regulatory and cellular functions.果蝇中的JAK/STAT信号传导：对保守调控和细胞功能的见解
Development. 2006 Jul;133(14):2605-16. doi: 10.1242/dev.02411.
9
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.Jak-STAT信号通路以及对干扰素和其他细胞外信号蛋白的转录激活。
Science. 1994 Jun 3;264(5164):1415-21. doi: 10.1126/science.8197455.
Zotero 插件